Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs
Crossref DOI link: https://doi.org/10.1007/s00280-015-2920-7
Published Online: 2016-01-25
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Phillips, Roger M.
License valid from 2016-01-25